首页 | 本学科首页   官方微博 | 高级检索  
检索        

猕猴血浆中SARS冠状病毒主蛋白酶肽类抑制剂N3的测定
引用本文:王明媚,王清清,向慎思,杨杰,贾彦波,宋海峰,傅晟,郝一鸣.猕猴血浆中SARS冠状病毒主蛋白酶肽类抑制剂N3的测定[J].解放军药学学报,2013(5):424-427.
作者姓名:王明媚  王清清  向慎思  杨杰  贾彦波  宋海峰  傅晟  郝一鸣
作者单位:[1]军事医学科学院放射与辐射医学研究所药理毒理研究室,北京100850 [2]解放军总医院第一附属医院药剂药理科,北京100048 [3]天津市国际生物医药联合研究院,天津300457
摘    要:目的建立测定猕猴血浆中N3的LC-MS/MS法。方法以ffiOBasiCC18(100mm×2.1 mm,5μm)色谱柱为 分析柱,流动相为乙腈-水(含0.2%甲酸)(55:45, F:F),采用电喷雾离子源(ESI),正离子扫描方式,选择离子反应监测 (SRM)模式检测,用于定量分析的离子反应为m/z681.3-402.3。结果血浆中的N3用乙腈沉淀蛋白后,样品经LC-MS/MS 系统进行检测。在优化后的样品预处理、色谱及质谱条件下,LC-MS/MS法检测猕猴血浆中的N3,线性范围为20 -2500 μg·L^-1,准确度RE范围为-12.9% -2. 9 %,日内、日间精密度的RSD分别小于7.5% ( n =6)和7.8% ( n =18);低、中、高 3个浓度(50、1000和2000μg·L^-1)犯质控样品的提取回收率分别为75.5 %、77.3 %和79.6 %。结论结果表明,该方法 具有灵敏、准确、快速等优点,适用于N3在猕猴体内的药代动力学研究。

关 键 词:肽类药物  LC—MS  MS  猕猴血浆  药代动力学

Determination of Peptide Inhibitor N3 of SARS Corona-virus Main Protease in Rhesus Plasma
WANG Ming-mei①②,WANG Qing-qing①,XIANG Shen-si①,YANG Jie①,JIA Yan-bo①,SONG Hai-feng①,FU Sheng③,HAO Yi-ming.Determination of Peptide Inhibitor N3 of SARS Corona-virus Main Protease in Rhesus Plasma[J].Pharmaceutical Journal of Chinese People's Liberation Army,2013(5):424-427.
Authors:WANG Ming-mei①②  WANG Qing-qing①  XIANG Shen-si①  YANG Jie①  JIA Yan-bo①  SONG Hai-feng①  FU Sheng③  HAO Yi-ming
Institution:③① Department of Pharmacology and Toxicology, Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China ; ②Department of Pharmacy, the First Affiliated Hospital of PLA General Hospital,Beijing 100048,China;③Tianjin International Joint Academy of Biotechnology & Medicine, Tianjin 300457, China
Abstract:Objective To develop a high performance LC-MS/MS method for the determination of N3 in rhesus plasma. Methods The analysis was performed on a BioBasic C18 column (100mm×2.1 mm,5μm) with acetonitrile-water ( containing 0. 2% formic acid) ( 55 : 45,V :V ) as the mobile phase. A mass spectrometer equipped with electrospray ionization (ESI) source was used as the detector and operated in the positive ion mode. The selected reactions monitoring (SRM) mode with the transitions of m/z 681. 3/402. 2 was used to quantify N3. Results N3 in rhesus plasma was extracted by protein precipitation with acetonitrile,and the supernatant was injec-ted into the LC-MS/MS system for determination. Under optimized LC-MS/MS conditions, the standard curve was linear over the concentration range of 20 - 2500 μg·L^-1 for N3. The accuracy ( relative error,RE) of this method ranged from - 12. 9% to 2. 9% . The intra-day and inter-day precision ( relative standard deviation, RSD) was less than 7. 5% ( n =6) and 7. 8% ( n =18),respectively. The recovery of the method for N3 of 50, 1000 and 2000μg·L^-1 in rhesus plasma was 75. 0% ,76. 9% and 79. 5% ,respectively. Conclusion The established method is shown to be sensitive,accurate,quick and effective for investigation of N3 pharmacokinetics in rhesus.
Keywords:peptide drug  LC-MS/MS  rhesus plasma  pharmacokinetics
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号